Macrogenics Inc
MGNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001125345
In the last 90 days, Macrogenics Inc insiders filed 0 open-market purchases and 1 sale; 122 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Macrogenics Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +5 vs. Q3 2024
- Shares held
- 56.1M
- +389.4K (+0.7%) vs. Q3 2024
- Total value
- $182.5M
- −$5.41M (−2.9%) vs. Q3 2024
- New holders
- 23
- 41 more added
- Sold out
- 18
- 38 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $224.9M |
| Q1 2026 | 109 | $124.8M |
| Q4 2025 | 89 | $64.3M |
| Q3 2025 | 104 | $77.4M |
| Q2 2025 | 112 | $58.5M |
| Q1 2025 | 129 | $68.3M |
| Q4 2024 | 129 | $182.5M |
| Q3 2024 | 124 | $187.9M |
| Q2 2024 | 147 | $258.9M |
| Q1 2024 | 163 | $953.6M |
| Q4 2023 | 143 | $595.1M |
| Q3 2023 | 127 | $270.5M |
| Q2 2023 | 131 | $321.1M |
| Q1 2023 | 137 | $419.1M |
| Q4 2022 | 135 | $380.5M |
| Q3 2022 | 135 | $199.0M |
| Q2 2022 | 133 | $184.9M |
| Q1 2022 | 144 | $531.2M |
| Q4 2021 | 156 | $918.1M |
| Q3 2021 | 154 | $1.21B |
| Q2 2021 | 149 | $1.54B |
| Q1 2021 | 174 | $1.80B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Macrogenics Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 323,857 | $1.05M | 0.00% | +16,717+5.4% | Added |
| Goldman Sachs Group Inc | 351,136 | $1.14M | 0.00% | +122,690+53.7% | Added |
| Marshall Wace, LLP | 393,766 | $1.28M | 0.00% | +12,250+3.2% | Added |
| Macquarie Group Ltd | 420,000 | $1.36M | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 454,337 | $1.48M | 0.00% | −67,860−13.0% | Reduced |
| Price T Rowe Associates Inc | 485,987 | $1.58M | 0.00% | −768,249−61.3% | Reduced |
| Pinnacle Associates Ltd | 501,850 | $1.63M | 0.02% | −186,130−27.1% | Reduced |
| Charles Schwab Investment Management Inc | 527,185 | $1.71M | 0.00% | +34,420+7.0% | Added |
| Renaissance Technologies LLC | 538,523 | $1.75M | 0.00% | +220,100+69.1% | Added |
| Northern Trust Corp | 540,970 | $1.76M | 0.00% | −161,850−23.0% | Reduced |
| JPMorgan Chase & Co | 546,807 | $1.78M | 0.00% | +221,905+68.3% | Added |
| Jacobs Levy Equity Management, Inc | 565,904 | $1.84M | 0.01% | −424−0.1% | Reduced |
| Dimensional Fund Advisors LP | 717,288 | $2.33M | 0.00% | −165,372−18.7% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 744,902 | $2.42M | 0.01% | +82,988+12.5% | Added |
| Schonfeld Strategic Advisors LLC | 857,505 | $2.79M | 0.02% | +857,505 | New |
| Two Sigma Investments, LP | 860,745 | $2.80M | 0.01% | −22,624−2.6% | Reduced |
| Rock Springs Capital Management LP | 1,053,647 | $3.42M | 0.13% | 00.0% | Unchanged |
| Morgan Stanley | 1,104,426 | $3.59M | 0.00% | +784,557+245.3% | Added |
| Two Sigma Advisers, LP | 1,118,600 | $3.64M | 0.01% | +74,596+7.1% | Added |
| Acadian Asset Management LLC | 1,290,923 | $4.19M | 0.01% | +199,098+18.2% | Added |
| Geode Capital Management, LLC | 1,433,217 | $4.66M | 0.00% | +26,341+1.9% | Added |
| State Street Corp | 1,462,532 | $4.75M | 0.00% | +35,142+2.5% | Added |
| Millennium Management LLC | 2,864,721 | $9.31M | 0.01% | −671,179−19.0% | Reduced |
| Frazier Life Sciences Management, L.P. | 3,175,665 | $10.3M | 0.43% | +164,938+5.5% | Added |
| Wasatch Advisors Inc | 3,488,493 | $11.3M | 0.06% | +952,691+37.6% | Added |
| Vanguard Group Inc | 4,316,681 | $14.0M | 0.00% | −40,859−0.9% | Reduced |
| BlackRock, Inc. | 5,057,175 | $16.4M | 0.00% | −348,297−6.4% | Reduced |
| Armistice Capital, LLC | 6,276,000 | $20.4M | 0.47% | +18,000+0.3% | Added |
| Bellevue Group AG | 9,929,963 | $32.3M | 0.62% | 00.0% | Unchanged |
| Franklin Resources Inc | 0 | $0 | 0.00% | −107,293−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −119,029−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −90,304−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −72,879−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −56,018−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −41,706−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −40,754−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −37,170−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −32,775−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −29,615−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −28,173−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −19,694−100.0% | Sold out |
| Northeast Financial Consultants Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −3,135−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −1,462−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −639−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −327−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −190−100.0% | Sold out |